Sa. Aicher et al., mu-opioid receptors are present in functionally identified sympathoexcitatory neurons in the rat rostral ventrolateral medulla, J COMP NEUR, 433(1), 2001, pp. 34-47
Agonists of the mu -opioid receptor (MOR) produce profound hypotension and
sympathoinhibition when microinjected into the rostral ventrolateral medull
a (RVL). These effects are likely to be mediated by the inhibition of adren
ergic and other presympathetic vasomotor neurons located in the RVL. The pr
esent ultrastructural studies were designed to determine whether these vaso
motor neurons, or their afferents, contain MORs. RVL bulbospinal barosensit
ive neurons were recorded in anesthetized rats and filled individually with
biotinamide by using a juxtacellular labeling method. Biotinamide was visu
alized by using a peroxidase method and MOR was identified by using immunog
old localization of an antipeptide antibody that recognizes the cloned MOR,
MOR1. The subcellular relationship of MOR1 to RVL neurons with fast- or sl
ow-conducting spinal axons was examined by electron microscopy. Fast- and s
low-conducting cells were not morphologically distinguishable. Immunogold-l
abeling for MOR1 was found in all RVL bulbospinal barosensitive neurons exa
mined (9 of 9). MOR1 was present in 52% of the dendrites from both types of
cells and in approximately half of these dendrites the MOR1 was at nonsyna
ptic plasmalemmal sites. A smaller portion of biotinamide-labeled dendrites
(16%) from both types of cells were contacted by MOR1-containing axons or
axon terminals. Together, these results suggest that MOR agonists can direc
tly influence the activity of all types of RVL sympathoexcitatory neurons a
nd that MOR agonists may also influence the activity of afferent inputs to
these cells. The heterogenous distribution of MORs within individual RVL ne
urons indicates that the receptor is selectively targeted to specific pre-
and postsynaptic sites. (C) 2001 Wiley-Liss, Inc.